News >

Leveraging Locoregional Therapy and Resection in Metastatic CRC

Caroline Seymour
Published: Wednesday, May 15, 2019

Bassel El-Rayes, MD

Bassel El-Rayes, MD

Although resection is considered to be standard in the absence of long-term follow-up data regarding locoregional therapy, there are plenty of alternative approaches that, when applied with the utmost scrutiny, can be beneficial to patients with borderline and unresectable colorectal cancer (mCRC) that has metastasized to the liver, explained Bassel El-Rayes, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Individualizing Treatment After Second-Line Therapy for Patients With mCRCAug 29, 20191.0
Community Practice Connections™: Immunotherapeutic Strategies with the Potential to Transform Treatment for Genitourinary CancersAug 29, 20191.0
Publication Bottom Border
Border Publication